Number of the records: 1  

Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors

  1. 1.
    SYSNO ASEP0333998
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleMapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors
    Author(s) Dossi, K. (GR)
    Tsirkone, V.G. (GR)
    Hayes, J.M. (GR)
    Matoušek, Josef (UZFG-Y) RID
    Poučková, P. (CZ)
    Souček, J. (CZ)
    Zadinová, M. (CZ)
    Zographos, S.E. (GR)
    Leonidas, D.D. (GR)
    Source TitleEuropean Journal of Medicinal Chemistry. - : Elsevier - ISSN 0223-5234
    Roč. 44, č. 11 (2009), s. 4496-4508
    Number of pages13 s.
    Languageeng - English
    CountryFR - France
    Keywordsbovine seminal ribonuclease ; antitumor agent
    Subject RIVGJ - Animal Vermins ; Diseases, Veterinary Medicine
    CEZAV0Z50450515 - UZFG-Y (2005-2011)
    UT WOS000271225800028
    DOI10.1016/j.ejmech.2009.06.039
    AnnotationBovine seminal ribonuclease(BS-RNase) is a 27 kDa homodimeric enzyme and a member of the pancreatic RNase A superfamily.It is the only RNase with a quaternary structure and it is a mixture of two dimeric forms.In the most abundant form the active site is formed by the swapping of the N-terminal segments.BS-RNase is a potent antitumor agent with severe side effects such as aspermatogenicity,and immunosuppression.As a first step towards the design of potent inhibitors of this enzyme we mapped its active site through the study of the binding of uridine 2'-phosphate(U2'p),uridine T-phosphate(U3'p),uridine 5'-diphosphate UDP),cytidine T-phosphate(C3'p),and cytidine 5-phosphate (C5'p),by kinetics,and Xray crystallography.These phosphonucleotides are potent inhibitors with C3'p being the most potent with a K-i value of 22 mu M. Absorption,distribution, metabolism, and excretion pharmacokinetic property predictions reveal U2'p, U3'p, and C5'p as the most promising with respect to oral bioavailability.In vivo studies on the aspermatogenic effect have shown that C3'p and C5'p inhibitsignificantly this biological action of BS-RNase.
    WorkplaceInstitute of Animal Physiology and Genetics
    ContactJana Zásmětová, knihovna@iapg.cas.cz, Tel.: 315 639 554
    Year of Publishing2010
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.